Search
Poppy seed
go.drugbank.com/drugs/DB10681ApprovedPoppy seed allergenic extract is used in allergenic testing.
Categories: Non-Standardized Food Allergenic Extract, Non-Standardized Plant Allergenic ExtractAmerican chestnut
go.drugbank.com/drugs/DB10686ApprovedAmerican chestnut allergenic extract is used in allergenic testing.
Categories: Non-Standardized Food Allergenic Extract, Non-Standardized Plant Allergenic ExtractBasil
go.drugbank.com/drugs/DB10829ApprovedBasil allergenic extract is used in allergenic testing.
Categories: Non-Standardized Food Allergenic Extract, Non-Standardized Plant Allergenic ExtractCapsicum
go.drugbank.com/drugs/DB10897ApprovedCapsicum (Chili pepper) allergenic extract is used in allergenic testing.
Categories: Non-Standardized Food Allergenic Extract, Non-Standardized Plant Allergenic ExtractSafflower
go.drugbank.com/drugs/DB10905ApprovedSafflower allergenic extract is used in allergenic testing.
Categories: Non-Standardized Food Allergenic Extract, Non-Standardized Plant Allergenic ExtractBarley malt
go.drugbank.com/drugs/DB10980ApprovedBarley malt allergenic extract is used in allergenic testing.
Mixtures: Immune Essence to Prolong Life, Immune Essence to Prolong LifeCategories: Non-Standardized Food Allergenic Extract, Non-Standardized Plant Allergenic ExtractSage
go.drugbank.com/drugs/DB10982ApprovedSage allergenic extract is used in allergenic testing.
Categories: Non-Standardized Food Allergenic Extract, Non-Standardized Plant Allergenic ExtractAmerican hazelnut
go.drugbank.com/drugs/DB15612ApprovedAmerican hazelnut allergenic extract is used in allergenic testing.
Categories: Non-Standardized Food Allergenic Extract, Non-Standardized Plant Allergenic ExtractSIG-007
go.drugbank.com/drugs/DB17710ExperimentalDeveloped by Sigilon Therapeutics, t is being investigated for the treatment of Fabry Disease.[L46153] … SIG-007 is a gene therapy that consists of cells that are genetically modified with a non-viral vector to express human alpha-galactosidase A.
Hu-rhEGF-rP64k/Mont
go.drugbank.com/drugs/DB15781InvestigationalHu-rhEGF-rP64k/Mont is a therapeutic vaccine composed by an antigen (recombinant human EGF (rhEGF) chemically conjugated to recombinant P64K (rP64K)) and an adjuvant (Montanide ISA51VG) being investigated … for the treatment of advanced non-small cell lung cancer (NSCLC).